Cargando…

Four Decades of Prophylactic EBV Vaccine Research: A Systematic Review and Historical Perspective

BACKGROUND: Epstein-Barr virus (EBV) is the causal agent of infectious mononucleosis and has been associated with various cancers and autoimmune diseases. Despite decades of research efforts to combat this major global health burden, there is no approved prophylactic vaccine against EBV. To facilita...

Descripción completa

Detalles Bibliográficos
Autores principales:	Escalante, Gabriela M., Mutsvunguma, Lorraine Z., Muniraju, Murali, Rodriguez, Esther, Ogembo, Javier Gordon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047024/ https://www.ncbi.nlm.nih.gov/pubmed/35493498 http://dx.doi.org/10.3389/fimmu.2022.867918

Ejemplares similares

A Pentavalent Epstein-Barr Virus-Like Particle Vaccine Elicits High Titers of Neutralizing Antibodies against Epstein-Barr Virus Infection in Immunized Rabbits
por: Escalante, Gabriela M., et al.
Publicado: (2020)

Suppression of DC-SIGN and gH Reveals Complex, Subset-Specific Mechanisms for KSHV Entry in Primary B Lymphocytes
por: Palmerin, Nancy, et al.
Publicado: (2021)

Prophylactic and Therapeutic EBV Vaccines: Major Scientific Obstacles, Historical Progress, and Future Direction
por: Cai, Jing, et al.
Publicado: (2021)

EBV-induced T-cell responses in EBV-specific and nonspecific cancers
por: Zhang, Qiuting, et al.
Publicado: (2023)

Development of an Improved Epstein-Barr Virus (EBV) Neutralizing Antibody Assay to Facilitate Development of a Prophylactic gp350-Subunit EBV Vaccine
por: Liu, Hui, et al.
Publicado: (2020)

Progress in Prophylactic and Therapeutic EBV Vaccine Development Based on Molecular Characteristics of EBV Target Antigens
por: Rozman, Marija, et al.
Publicado: (2022)

Novel Epstein-Barr virus-like particles incorporating gH/gL-EBNA1 or gB-LMP2 induce high neutralizing antibody titers and EBV-specific T-cell responses in immunized mice
por: Perez, Elizabeth M., et al.
Publicado: (2016)

HPV genotyping by L1 amplicon sequencing of archived invasive cervical cancer samples: a pilot study
por: Warden, Charles D., et al.
Publicado: (2022)

Mendelian randomisation identifies priority groups for prophylactic EBV vaccination
por: Muckian, Marisa D., et al.
Publicado: (2023)

Epstein-Barr Virus (EBV)-Related Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM Regulate EBV Life Cycle?
por: Tatfi, Moussab, et al.
Publicado: (2019)

GMP development and preclinical validation of CAR-T cells targeting a lytic EBV antigen for therapy of EBV-associated malignancies
por: Zhang, Xi, et al.
Publicado: (2023)

Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma
por: Li, Wenting, et al.
Publicado: (2023)

Camelid Single-Domain Antibodies: Historical Perspective and Future Outlook
por: Arbabi-Ghahroudi, Mehdi
Publicado: (2017)

Editorial: EBV Infection and Human Primary Immune Deficiencies
por: Cohen, Jeffrey I., et al.
Publicado: (2020)

EBV-associated diseases: Current therapeutics and emerging technologies
por: Chakravorty, Srishti, et al.
Publicado: (2022)

Four decades of measuring stillbirths and neonatal deaths in Demographic and Health Surveys: historical review
por: Akuze, Joseph, et al.
Publicado: (2021)

Revisiting the Tissue Microenvironment of Infectious Mononucleosis: Identification of EBV Infection in T Cells and Deep Characterization of Immune Profiles
por: Barros, Mário Henrique M., et al.
Publicado: (2019)

Regulatory T-Cells in Pregnancy: Historical Perspective, State of the Art, and Burning Questions
por: Ruocco, Maria Grazia, et al.
Publicado: (2014)

Major Scientific Hurdles in HIV Vaccine Development: Historical Perspective and Future Directions
por: Ng’uni, Tiza, et al.
Publicado: (2020)

Glycoprotein B Antibodies Completely Neutralize EBV Infection of B Cells
por: Hong, Junping, et al.
Publicado: (2022)

Cancer Immunotherapy: Historical Perspective of a Clinical Revolution and Emerging Preclinical Animal Models
por: Decker, William K., et al.
Publicado: (2017)

Prevention of Pediatric Respiratory Syncytial Virus Lower Respiratory Tract Illness: Perspectives for the Next Decade
por: Aranda, Sofia S., et al.
Publicado: (2019)

Overall avidity declines in TCR repertoires during latent CMV but not EBV infection
por: Couturaud, Barbara, et al.
Publicado: (2023)

Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases
por: Cui, Xinle, et al.
Publicado: (2021)

The Outcome of Induction Therapy for EBV-Related Hemophagocytic Lymphohistiocytosis: A Model for Risk Stratification
por: Cui, Tingting, et al.
Publicado: (2022)

Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine
por: Zhou, Xu, et al.
Publicado: (2020)

A chimeric EBV gp350/220-based VLP replicates the virion B-cell attachment mechanism and elicits long-lasting neutralizing antibodies in mice
por: Ogembo, Javier Gordon, et al.
Publicado: (2015)

Four Decades of Carrier Detection and Prenatal Diagnosis in Hemophilia A: Historical Overview, State of the Art and Future Directions
por: Dardik, Rima, et al.
Publicado: (2023)

Modification of EBV Associated Lymphomagenesis and Its Immune Control by Co-Infections and Genetics in Humanized Mice
por: Schuhmachers, Patrick, et al.
Publicado: (2021)

What do animal models tell us about the role of EBV in the pathogenesis of multiple sclerosis?
por: Hassani, Asma, et al.
Publicado: (2022)

Complement Component C1q: Historical Perspective of a Functionally Versatile, and Structurally Unusual, Serum Protein
por: Reid, Kenneth B. M.
Publicado: (2018)

Approaching two decades of cystic fibrosis research in Qatar: a historical perspective and future directions
por: Hammoudeh, Samer, et al.
Publicado: (2019)

Prophylactic Treatment of Pediatric Migraine: Is There Anything New in the Last Decade?
por: Papetti, Laura, et al.
Publicado: (2019)

Viral Pandemics of the Last Four Decades: Pathophysiology, Health Impacts and Perspectives
por: Roychoudhury, Shubhadeep, et al.
Publicado: (2020)

Case Report: Primary Immunodeficiencies, Massive EBV+ T-Cell Lympoproliferation Leading to the Diagnosis of ICF2 Syndrome
por: Padeira, Gonçalo Luzes, et al.
Publicado: (2021)

Long-lasting responses with chemotherapy followed by T-cell therapy in recurrent or metastatic EBV-related nasopharyngeal carcinoma
por: Secondino, Simona, et al.
Publicado: (2023)

Prophylactic Tocilizumab Prior to Anti-CD19 CAR-T Cell Therapy for Non-Hodgkin Lymphoma
por: Caimi, Paolo F., et al.
Publicado: (2021)

The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease
por: Garbuglia, Anna Rosa, et al.
Publicado: (2020)

The Status and Prospects of Epstein–Barr Virus Prophylactic Vaccine Development
por: Sun, Cong, et al.
Publicado: (2021)

The Primate EAE Model Points at EBV-Infected B Cells as a Preferential Therapy Target in Multiple Sclerosis
por: ‘T Hart, Bert A., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_l0qk36jr8l889r93j74udlk5cr